Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$5.59 +0.12 (+2.19%)
At close: Oct 23, 2026 · 4:00 PM EDT

Orchestra BioMed Holdings (OBIO) Long-Term Debt Repayments (2022)

Updated

Orchestra BioMed Holdings' Long-Term Debt Repayments was $10.85 million in FY2023, up 68.3% from $6.45 million in FY2022.

Analysis

Orchestra BioMed Holdings (OBIO) Long-Term Debt Repayments (2022) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Repayments in earlier years was $6.45 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn -
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn 1.41 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn -
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn -
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn -
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn -
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn -
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn 2.00 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn -
10 Orchestra BioMed Holdings 354.80 Mn -51.90 Mn 63,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 5.45 Mn
Mar 31, 2022 1.00 Mn
API Access

Orchestra BioMed Holdings Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=OBIO&period=max&api_key=YOUR_API_KEY